Lantern Pharma Inc. (LTRN)
NASDAQ$3.75
Market Cap
$40.44M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
692 of 924
Rank in Industry
395 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
LTRN Insider Trading Activity
LTRN Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $378,200 | 4 | 100 |
Related Transactions
| Fletcher Aaron G.L. | 10 percent owner | 0 | $0 | 2 | $189,100 | $-189,100 |
| Kreis Leslie W. | 10 percent owner | 0 | $0 | 2 | $189,100 | $-189,100 |
About Lantern Pharma Inc.
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA …
Insider Activity of Lantern Pharma Inc.
Over the last 12 months, insiders at Lantern Pharma Inc. have bought $0 and sold $378,200 worth of Lantern Pharma Inc. stock.
On average, over the past 5 years, insiders at Lantern Pharma Inc. have bought $150,000 and sold $2.11M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $150,000 was made by KEYSER D JEFFREY (director) on 2020‑06‑11.
List of Insider Buy and Sell Transactions, Lantern Pharma Inc.
| 2024-05-24 | Sale | Kreis Leslie W. | 10 percent owner | 20,000 0.1889% | $6.33 | $126,600 | -37.48% | |
| 2024-05-24 | Sale | Fletcher Aaron G.L. | 10 percent owner | 20,000 0.1889% | $6.33 | $126,600 | -37.48% | |
| 2024-05-23 | Sale | Kreis Leslie W. | 10 percent owner | 10,000 0.0932% | $6.25 | $62,500 | -37.08% | |
| 2024-05-23 | Sale | Fletcher Aaron G.L. | 10 percent owner | 10,000 0.0932% | $6.25 | $62,500 | -37.08% | |
| 2024-02-29 | Sale | Kreis Leslie W. | 10 percent owner | 19,703 0.1653% | $4.87 | $95,954 | -11.64% | |
| 2024-02-29 | Sale | Fletcher Aaron G.L. | 10 percent owner | 19,703 0.1653% | $4.87 | $95,954 | -11.64% | |
| 2024-02-28 | Sale | Kreis Leslie W. | 10 percent owner | 74,297 0.6556% | $4.85 | $360,340 | -16.27% | |
| 2024-02-28 | Sale | Fletcher Aaron G.L. | 10 percent owner | 74,297 0.6556% | $4.85 | $360,340 | -16.27% | |
| 2024-02-27 | Sale | Kreis Leslie W. | 10 percent owner | 50,000 0.4668% | $4.40 | $220,000 | -4.89% | |
| 2024-02-27 | Sale | Fletcher Aaron G.L. | 10 percent owner | 50,000 0.4668% | $4.40 | $220,000 | -4.89% | |
| 2024-01-17 | Sale | Kreis Leslie W. | 10 percent owner | 58,889 0.6101% | $4.20 | $247,334 | +11.26% | |
| 2024-01-17 | Sale | Fletcher Aaron G.L. | 10 percent owner | 58,889 0.6101% | $4.20 | $247,334 | +11.26% | |
| 2023-11-29 | Sale | Kreis Leslie W. | 10 percent owner | 145,348 1.1501% | $3.44 | $499,997 | +7.42% | |
| 2023-11-29 | Sale | Fletcher Aaron G.L. | 10 percent owner | 145,348 1.1501% | $3.44 | $499,997 | +7.42% | |
| 2022-11-08 | Sale | Kreis Leslie W. | director | 350,000 3.233% | $4.40 | $1.54M | +13.90% | |
| 2022-11-08 | Sale | Fletcher Aaron G.L. | director | 350,000 3.233% | $4.40 | $1.54M | +13.90% | |
| 2022-09-02 | Sale | BP Directors, LP | 1,275 0.0118% | $5.20 | $6,630 | -3.08% | ||
| 2022-09-02 | Sale | BIOS Advisors GP, LLC | 1,275 0.0118% | $5.20 | $6,630 | -3.08% | ||
| 2020-06-11 | KEYSER D JEFFREY | director | 10,000 0.369% | $15.00 | $150,000 | +5.48% |
Total: 19
*Gray background shows transactions not older than one year
Insider Historical Profitability
5.48%
| KEYSER D JEFFREY | director | 10000 0.0927% | $37,500.00 | 1 | 0 | +5.48% |
Historical Insider Profitability vs. Competitors
$1,695,621 | 55 | 17.90% | $42.95M | |
$140,938,207 | 36 | 14.75% | $40.58M | |
$23,895,365 | 34 | -37.28% | $35.88M | |
$241,165 | 22 | -16.72% | $37.75M | |
$167,476,357 | 20 | -1.54% | $40.57M |
LTRN Institutional Investors: Active Positions
| Increased Positions | 14 | +35% | 1M | +98.98% |
| Decreased Positions | 16 | -40% | 180,027 | -13.37% |
| New Positions | 6 | New | 1M | New |
| Sold Out Positions | 6 | Sold Out | 43,990 | Sold Out |
| Total Postitions | 38 | -5% | 2M | +85.62% |
LTRN Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Bios Capital Management, Lp | $4,589.00 | 10.98% | 1.21M | +1M | New | 2024-12-31 |
| Vanguard Group Inc | $1,382.00 | 3.31% | 363,720 | 0 | 0% | 2024-12-31 |
| Cm Management, Llc | $760.00 | 1.82% | 200,000 | +15,000 | +8.11% | 2024-12-31 |
| Renaissance Technologies Llc | $332.00 | 0.79% | 87,300 | +3,300 | +3.93% | 2024-12-31 |
| Geode Capital Management, Llc | $330.00 | 0.79% | 86,973 | -462 | -0.53% | 2024-12-31 |
| Newedge Advisors, Llc | $260.00 | 0.62% | 68,359 | -68,979 | -50.23% | 2024-12-31 |
| Voss Capital, Lp | $190.00 | 0.46% | 50,000 | +50,000 | New | 2024-12-31 |
| Blackrock, Inc. | $154.00 | 0.37% | 40,596 | +116 | +0.29% | 2024-12-31 |
| Citadel Advisors Llc | $143.00 | 0.34% | 37,587 | +35,434 | +1,645.8% | 2024-12-31 |
| Redmond Asset Management, Llc | $142.00 | 0.34% | 37,270 | -1,650 | -4.24% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.